Skip to main content
. 2015 Sep 15;32(1):42–50. doi: 10.1016/j.joa.2015.08.001

Table 3b.

Clinical course of case B.

CCr (mL/min) Anti-factor Xa activity (IU/mL) PT (s) APTT (s)
Before 24.4 11.0 33.3
Apixaban (trough)
(14th day) 2.5 mg twice daily 16.5 3.18 19.4 40.3
(22nd day) 2.5 mg once daily 17.0 1.79 14.9 37.9
(36th day) 2.5 mg once daily 15.1 1.73 14.9 38.3
(53rd day) 2.5 mg once for every other day 6.0 2.53 16.4 41.8